Medicare Enrolled
Dr. Sophia Mirviss, M.D.
Family Medicine · Berkeley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mirviss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mirviss?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mirviss
Dr. Sophia Mirviss is a family medicine specialist in Berkeley, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mirviss performed 3,767 Medicare services across 3,212 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mirviss received a total of $11,169 from 55 pharmaceutical and/or device companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mirviss is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$11,169 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,767
Medicare services
Top 5% in CA for family medicine
3,212
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~198 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
825 | $71 | $145 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
453 | $107 | $220 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
418 | $30 | $39 |
| Annual alcohol misuse screening, 5 to 15 minutes | 417 | $23 | $35 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
414 | $92 | $155 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
390 | $154 | $230 |
| Annual depression screening | 384 | $23 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
99 | $36 | $45 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
96 | $72 | $85 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
45 | $282 | $325 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
44 | $36 | $45 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
39 | $41 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
36 | $161 | $275 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
25 | $12 | $60 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
21 | $195 | $245 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
20 | $51 | $150 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
17 | $5 | $75 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
13 | $11 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $45 | $95 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,169
Total received (2018-2024)
Avg $1,596/year across 7 years
Top 4% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
528
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,000 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$169 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,650
2023
$1,687
2022
$1,500
2021
$1,578
2020
$1,118
2019
$1,334
2018
$2,301
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$332
Lilly USA, LLC
$223
AstraZeneca Pharmaceuticals LP
$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$148
GlaxoSmithKline, LLC.
$133
Otsuka America Pharmaceutical, Inc.
$123
Lundbeck LLC
$117
Bayer Healthcare Pharmaceuticals Inc.
$83
Novo Nordisk Inc
$68
PFIZER INC.
$59
Amgen Inc.
$54
Exact Sciences Corporation
$47
Astellas Pharma US Inc
$41
Collegium Pharmaceutical, Inc.
$37
Verity Pharmaceuticals Inc.
$14
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,009
PFIZER INC.
$976
Boehringer Ingelheim Pharmaceuticals, Inc.
$936
GlaxoSmithKline, LLC.
$889
Lilly USA, LLC
$876
AstraZeneca Pharmaceuticals LP
$749
ITI, Inc.
$583
AbbVie Inc.
$574
Amgen Inc.
$416
SANOFI-AVENTIS U.S. LLC
$375
Gilead Sciences, Inc.
$294
Allergan, Inc.
$281
Astellas Pharma US Inc
$271
Merck Sharp & Dohme Corporation
$203
Takeda Pharmaceuticals U.S.A., Inc.
$195
Biohaven Pharmaceutical Holding Company Ltd.
$175
Teva Pharmaceuticals USA, Inc.
$171
Regeneron Healthcare Solutions, Inc.
$151
Lundbeck LLC
$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$148
Bayer Healthcare Pharmaceuticals Inc.
$141
Novo Nordisk Inc
$139
Eisai Inc.
$126
Otsuka America Pharmaceutical, Inc.
$123
Daiichi Sankyo Inc.
$121
AbbVie, Inc.
$97
Amarin Pharma Inc.
$81
Janssen Pharmaceuticals, Inc
$74
Biohaven Pharmaceuticals, Inc.
$71
Bausch Health US, LLC
$56
SANOFI PASTEUR INC.
$54
Corium, LLC
$48
Exact Sciences Corporation
$47
EISAI INC.
$42
Allergan Inc.
$39
Collegium Pharmaceutical, Inc.
$37
Mannkind Corporation
$37
IDORSIA PHARMACEUTICALS US INC
$36
Avanir Pharmaceuticals, Inc.
$34
Alexion Pharmaceuticals, Inc.
$28
Insulet Corporation
$26
Bayer HealthCare Pharmaceuticals Inc.
$25
Esperion Therapeutics, Inc.
$25
Shire North American Group Inc
$24
AMAG Pharmaceuticals, Inc.
$24
Medline Industries, Inc.
$23
Xeris Pharmaceuticals, Inc.
$22
Genentech USA, Inc.
$22
IBSA Pharma Inc.
$21
Vanda Pharmaceuticals Inc.
$18
Pulmonx Corporation
$18
Janssen Biotech, Inc.
$17
Endo Pharmaceuticals Inc.
$17
Circassia Pharmaceuticals Inc
$17
Verity Pharmaceuticals Inc.
$14
Top 3 companies account for 26.2% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AFREZZA · AIRSUPRA · AJOVY · ANORO · AZSTARYS · Aimovig · AirDuo Digihaler · BASAGLAR · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Belbuca · CAPLYTA · CHANTIX · COLOGUARD · COMIRNATY · Cologuard Collection Kit · Creon · Dayvigo · Dexilant · EMGALITY · EVENITY · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · GLYXAMBI · GVOKE HYPOPEN · HETLIOZ · INJECTAFER · INTRAROSA · JANUVIA · JARDIANCE · Kerendia · LO LOESTRIN FE · MIGRANAL · MOUNJARO · MYFEMBREE · MYRBETRIQ · Myrbetriq · NASCOBAL · NEXLETOL · NUCALA · NURTEC ODT · Nuedexta · OFEV · OXBRYTA · Omnipod · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PREZCOBIX · Prolia · Pulmonx Endobronchial Valve EBV · QULIPTA · QUVIVIQ · QVAR · REXULTI · ROTATEQ · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Strensiq · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tirosint · Tlando · Trintellix · Truvada · UBRELVY · VRAYLAR · VYVANSE · Vascepa · Veozah · XARELTO · Xolair · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,603
Per 100K population
97.0
County median income
$126,240
Nearest hospital
ALTA BATES SUMMIT MEDICAL CENTER - ALTA BATES CAMP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mirviss is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mirviss experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mirviss performed 825 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mirviss receive payments from pharmaceutical companies?
Yes. Dr. Mirviss received a total of $11,169 from 55 companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mirviss's costs compare to other family medicine physicians in Berkeley?
Dr. Mirviss's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mirviss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Berkeley
Browse family medicine physicians in Berkeley ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology